C4 Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $55.6M | $54.3M | $1.3M | $1.6M |
| FY2020 | $-67.2M | $-67.9M | $650.0K | $3.4M |
| FY2021 | $-87.0M | $-88.2M | $1.3M | $21.5M |
| FY2022 | $-105.9M | $-111.4M | $5.5M | $30.0M |
| FY2023 | $-106.8M | $-108.5M | $1.7M | $27.2M |
| FY2024 | $-65.2M | $-65.3M | $180.0K | $29.7M |
| FY2025 | $-98.7M | $-99.3M | $607.0K | $19.1M |